1987
DOI: 10.1016/0882-4010(87)90110-0
|View full text |Cite
|
Sign up to set email alerts
|

Experimental murine tularemia caused by Francisella tularensis, live vaccine strain: a model of acquired cellular resistance

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
1

Citation Types

1
49
0

Year Published

1993
1993
2011
2011

Publication Types

Select...
10

Relationship

0
10

Authors

Journals

citations
Cited by 75 publications
(50 citation statements)
references
References 26 publications
1
49
0
Order By: Relevance
“…LVS infections in mice are similar to human infections with fully virulent F. tularensis (39). Since survival of sublethal LVS infection leads to strong and easily measurable secondary protective immunity to LVS, we (8,15,17,46) and others (2,18,40) have found the study of this infection in mice to be an informative in vivo model of immunity to intracellular pathogens. In contrast to the properties typically associated with LPS from many pathogens, LPS purified from LVS appears to lack many of the activities usually ascribed to this molecule.…”
mentioning
confidence: 92%
“…LVS infections in mice are similar to human infections with fully virulent F. tularensis (39). Since survival of sublethal LVS infection leads to strong and easily measurable secondary protective immunity to LVS, we (8,15,17,46) and others (2,18,40) have found the study of this infection in mice to be an informative in vivo model of immunity to intracellular pathogens. In contrast to the properties typically associated with LPS from many pathogens, LPS purified from LVS appears to lack many of the activities usually ascribed to this molecule.…”
mentioning
confidence: 92%
“…An attenuated 'live vaccine strain' (LVS) was derived by repeated passage of subsp. holarctica in the laboratory; despite the unclear nature of the attenuating mutation(s) in this strain, it is frequently used as a laboratory model for tularaemia (Anthony & Kongshavn, 1987;Eigelsbach et al, 1951). F. tularensis subsp.…”
mentioning
confidence: 99%
“…Despite being as infectious as biotype A, the lower virulence of the European biotype B enables laboratory work under containment level three conditions (Tarnvik and Berglund, 2003). Nevertheless, most experimental studies during the last three decades have used not virulent clinical isolates but the live vaccine strain (LVS) of F. tularensis attenuated for humans (Anthony and Kongshavn, 1987;Conlan et al, 1994;Green et al, 2005). However, there are genuine concerns about using F. tularensis LVS as a surrogate for more virulent strains of the pathogen .…”
Section: Discussionmentioning
confidence: 99%